Translocation t(11;18)(q21;q21) in gastric B-cell lymphomas

Cancer Science

Volumn 100, Issue 5, 2009, Pages 881-887

  Toracchio, Sonia ^a,b   Ota, Hiroyoshi ^c   de Jong, Daphne ^d   Wotherspoon, Andrew ^e   Rugge, Massimo ^f   Graham, David Y ^a   Samani, Amir ^g   El Zimaity, Hala M T ^a,g  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF CHIETI   (Italy)

^c SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d NETHERLANDS CANCER INSTITUTE   (Netherlands)

^e ROYAL MARSDEN HOSPITAL   (United Kingdom)

^f UNIVERSITY OF PADOVA   (Italy)

^g MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ACTIN;

ADOLESCENT; ADULT; AGED; ARTICLE; B CELL LYMPHOMA; CANCER GROWTH; CARCINOGENESIS; CHROMOSOME TRANSLOCATION 11; CHROMOSOME TRANSLOCATION 18; CONTROLLED STUDY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN TISSUE; ITALY; JAPAN; LARGE CELL LYMPHOMA; MALE; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH LYMPHOMA; UNITED STATES;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHROMOSOMES, HUMAN, PAIR 11; CHROMOSOMES, HUMAN, PAIR 18; FEMALE; HUMANS; LYMPHOMA, B-CELL; MALE; MIDDLE AGED; ONCOGENE PROTEINS, FUSION; STOMACH NEOPLASMS; TRANSLOCATION, GENETIC;

EID: 65349192229     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2009.01128.x     Document Type: Article

References (45)

1. Parsonnet J, Hansen S, Rodriguez L et al. Helicobacter pylori infection and gastric lymphoma. N Engl J Med 1994; 330: 1267-71.
2. Wotherspoon AC, Ortiz Hidalgo C, Falzon MR, Isaacson PG. Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma. Lancet 1991; 338: 1175-6.
3. Carlson SJ, Yokoo H, Vanagunas A. Progression of gastritis to monoclonal B-cell lymphoma with resolution and recurrence following eradication of Helicobacter pylori. JAMA 1996; 275: 937-9.
4. Chan JK, Ng CS, Isaacson PG. Relationship between high-grade lymphoma and low-grade B-cell mucosa-associated lymphoid tissue lymphoma (MALToma) of the stomach. Am J Pathol 1990; 136: 1153-64.
5. Murayama H, Kikuchi M, Eimoto T, Doki T, Doki K. Early lymphoma coexisting with reactive lymphoid hyperplasia of the stomach. Acta Pathol Jpn 1984; 34: 679-86.
6. Isaacson PG, Müller-Hermelink HK, Piris MA et al. Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma). In: Jaffe ES, Harris NL, Stein H, Vardiman JW, eds. World Health Organization Classification of tumours. Pathology, Genetics of Tumours of Haematopoietic, Lymphoid Tissues. Lyon: IARC Press, 2001: 157-60.
7. Ott G, Katzenberger T, Greiner A et al. The t(11;18) (q21;q21) chromosome translocation is a frequent and specific aberration in low-grade but not high-grade malignant non-Hodgkin's lymphomas of the mucosa-associated lymphoid tissue (MALT-) type. Cancer Res 1997; 57: 3944-8.
8. Akagi T, Motegi M, Tamura A et al. A novel gene, MALT1 at 18q21, is involved in t(11;18) (q21;q21) found in low-grade B-cell lymphoma of mucosa-associated lymphoid tissue. Oncogene 1999; 18: 5785-94.
9. Starostik P, Patzner J, Greiner A et al. Gastric marginal zone B-cell lymphomas of MALT type develop along 2 distinct pathogenetic pathways. Blood 2002; 99: 3-9.
10. Chuang SS, Lee C, Hamoudi RA et al. High frequency of t(11;18) in gastric mucosa-associated lymphoid tissue lymphomas in Taiwan, including one patient with high-grade transformation. Br J Haematol 2003; 120: 97-100.
11. Bertoni F, Zucca E. State-of-the-art therapeutics: Marginal-zone lymphoma. J Clin Oncol 2005; 23: 6415-20.
12. Liu H, Ye H, Ruskone-Fourmestraux A et al. T(11;18) is a marker for all stage gastric MALT lymphomas that will not respond to H. pylori eradication. Gastroenterology 2002; 122: 1286-94.
13. El-Zimaity HM, Ota H, Scott S, Killen DE, Graham DY. A new triple stain for Helicobacter pylori suitable for the autostainer: Carbol fuchsin/ Alcian blue/hematoxylin-eosin. Arch Pathol Lab Med 1998; 122: 732-6.
14. Musshoff K. Klinische Stadieneinteilung der Nicht-Hodgkin-Lymphome. [Classification of the clinical stages of non-Hodgkin's lymphoma]. Strahlentherapie 1977; 153: 218-21.
15. Toracchio S, El-Zimaity HMT, Urmacher C, Katz S, Graham DY. Mycobacterium avium subspecies paratuberculosis and Crohn's disease granulomas. Scand J Gastroenterol 2008; 43: 1108-11.
16. Inagaki H, Okabe M, Seto M, Nakamura S, Ueda R, Eimoto T. API2-MALT1 fusion transcripts involved in mucosa-associated lymphoid tissue lymphoma: Multiplex RT-PCR detection using formalin-fixed paraffin-embedded specimens. Am J Pathol 2001; 158: 699-706.
17. Jazaeri AA, Lu K, Schmandt R et al. Molecular determinants of tumor differentiation in papillary serous ovarian carcinoma. Mol Carcinog 2003; 36: 53-9.
18. Streubel B, Simonitsch-Klupp I, Müllauer L et al. Variable frequencies of MALT lymphoma-associated genetic aberrations in MALT lymphomas of different sites. Leukemia 2004; 18: 1722-6.
19. Dierlamm J, Baens M, Stefanova-Ouzounova M et al. Detection of t(11;18) (q21;q21) by interphase fluorescence in situ hybridization using API2 and MLT specific probes. Blood 2000; 96: 2215-8.
20. Remstein ED, James CD, Kurtin PJ. Incidence and subtype specificity of API2-MALT1 fusion translocations in extranodal, nodal, and splenic marginal zone lymphomas. Am J Pathol 2000; 156: 1183-8.
21. Yonezumi M, Suzuki R, Suzuki H et al. Detection of AP12-MALT1 chimaeric gene in extranodal and nodal marginal zone B-cell lymphoma by reverse transcription polymerase chain reaction (PCR) and genomic long and accurate PCR analyses. Br J Haematol 2001; 115: 588-94.
22. Baens M, Maes B, Steyls A, Geboes K, Marynen P, De Wolf-Peeters C. The product of the t(11;18), an API2-MLT fusion, marks nearly half of gastric MALT type lymphomas without large cell proliferation. Am J Pathol 2000; 156: 1433-9.
23. Nakamura S, Matsumoto T, Nakamura S et al. Chromosomal translocation t(11;18) (q21;q21) in gastrointestinal mucosa associated lymphoid tissue lymphoma. J Clin Pathol 2003; 56: 36-42.
24. Huang X, Zhang Z, Liu H et al. T(11;18) (q21;q21) in gastric MALT lymphoma and diffuse large B-cell lymphoma of Chinese patients. Hematol J 2003; 4: 342-5.
25. Sakugawa ST, Yoshino T, Nakamura S et al. API2-MALT1 fusion gene in colorectal lymphoma. Mod Pathol 2003; 16: 1232-41.
26. Takada S, Yoshino T, Taniwaki M et al. Involvement of the chromosomal translocation t(11;18) in some mucosa-associated lymphoid tissue lymphomas and diffuse large B/cell lymphomas of the ocular adnexa evidence from multiplex reverse transcriptase-polymerase chain reaction and fluorescence in situ hybridization on using formalin-fixed, paraffin-embedded specimens. Mod Pathol 2003; 16: 445-52.
27. Kuo SH, Chen LT, Yeh KH et al. Nuclear expression of BCL10 or Nuclear Factor Kappa B predicts Helicobacter pylori -independent status of early-stage, high-grade gastric mucosa-associated lymphoid tissue lymphomas. J Clin Oncol 2004; 22: 3491-7.
28. Tan SY, Ye H, Liu H et al. t(11;18) (q21;q21)-positive transformed MALT lymphoma. Histopathology 2008; 52: 777-80.
29. Bernasconi B, Karamitopolou-Diamantiis E, Tornillo L et al. Chromosomal instability in gastric mucosa-associated lymphoid tissue lymphomas: A fluorescent in situ hybridization study using a tissue microarray approach. Hum Pathol 2008; 39: 536-42.
30. Peng HM, Diss TC, Isaacson PG, Pan L. Genetic evidence for a clonal link between low and high-grade components in gastric MALT B-cell lymphoma. Histopathology 1997; 30: 425-9.
31. de Boer JP, Hiddink RF, Raderer M et al. Dissemination patterns in non-gastric MALT lymphoma. Haematologica 2008; 93: 201-6.
32. Vrieling C, de Jong D, Boot H, de Boer JP, Wegman F, Aleman BM. Long-term results of stomach-conserving therapy in gastric MALT lymphoma. Radiother Oncol 2008; 87: 405-11.
33. Jost PJ, Ruland J. Aberrant NF-κB signaling in lymphoma: mechanisms, consequences, and therapeutic implications. Blood 2007; 109: 2700-7.
34. Du M, Peng H, Singh N, Isaacson PG, Pan L. The accumulation of p53 abnormalities is associated with progression of mucosa-associated lymphoid tissue lymphoma. Blood 1995; 86: 4587-93.
35. Peng H, Diss TC, Isaacson PG, Pan L. c-myc gene abnormalities in mucosa-associated lymphoid tissue (MALT) lymphomas. J Pathol 1997; 181: 381-6.
36. Min KO, Seo EJ, Kwon HJ et al. Methylation of p 16 INK4A and p 57 KIP2 are involved in the development and progression of gastric MALT lymphomas. Mod Pathol 2006; 19: 141-8.
37. Johansson B, Mertens F, Mitelman F. Geographic heterogeneity of neoplasia-associated chromosome aberrations. Genes Chromosomes Cancer 1991; 3: 1-7.
38. Falush D, Wirth T, Linz B et al. Traces of human migrations in Helicobacter pylori populations. Science 2003; 299: 1582-5.
39. El-Zimaity HM, Wotherspoon A, de Jong D. Interobserver variation in the histopathological assessment of malt/malt lymphoma: Towards a consensus. Blood Cells Mol Dis 2005; 34: 6-16.
40. Iwano M, Watanabe N, Matsushima Y et al. Rapid development of diffuse large B-cell lymphoma after successful eradication of Helicobacter pylori for gastric MALT lymphoma. Am J Gastroenterol 2006; 101: 2878-83.
41. Kalla J, Stilgenbauer S, Schaffner C et al. Heterogeneity of the API2-MALT1 gene rearrangement in MALT-type lymphoma. Leukemia 2000; 14: 1967-74.
42. Motegi M, Yonezumi M, Suzuki H et al. API2-MALT1 chimeric transcripts involved in mucosa-associated lymphoid tissue type lymphoma predict heterogeneous products. Am J Pathol 2000; 156: 807-12.
43. Rosenwald A, Ott G, Stilgenbauer S et al. Exclusive detection of the t (11;18) (q21;q21) in extranodal marginal zone B cell lymphomas (MZBL) of MALT type in contrast to other MZBL and extranodal large B cell lymphomas. Am J Pathol 1999; 155: 1817-21.
44. Nakamura S, Ye H, Bacon CM et al. Translocations involving the immunoglobulin heavy chain gene locus predict better survival in gastric diffuse large B-cell lymphoma. Clin Cancer Res 2008; 14: 3002-10.
45. Streubel B, Huber D, Wohrer S, Chott A, Raderer M. Frequency of chromosomal aberrations involving MALT1 in mucosa-associated lymphoid tissue lymphoma in patients with Sjogren's syndrome. Clin Cancer Res 2004; 10: 476-80.